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Abstract 
Background: Heart failure has high morbidity and mortality and the incidence increases with 
age. Most randomized studies in heart failure were conducted in younger heart failure patients, 
despite the fact that the majority of the heart failure population is elderly. Therefore, the clinical 
phenotype and prognosis in elderly heart failure patients have been inadequately studied. 
Aims: To characterize the clinical phenotype and study the prognosis of the elderly heart failure 
population, with focus on co-morbidities and biomarkers in three main categories of heart 
failure:  heart failure with reduced ejection fraction (HFrEF), HF with preserved ejection 
fraction (HFpEF) and post-infarction HF. 
Methods: This thesis comprises four parts: 1) a retrospective study on differences in clinical 
phenotype between the younger and older heart failure populations and between different heart 
failure categories in 24236 patients by accessing The Swedish Heart Failure Registry;  2) a 
prospective study on the correlation between red cell distribution width (RDW) and cardiac 
function between different heart failure categories in 296 patients referred for echocardiography; 
3) a prospective study of 138 elderly acute coronary syndrome (ACS) patients, on prognosis in 
terms of major adverse cardiovascular events (MACE), including post-ACS heart failure and 
quality of life during a 3 year follow-up; 4) a retrospective study of 494 patients on all cause 
mortality and factors influencing mortality in different heart failure categories after 5 years of 
follow-up.  
Results: When compared to the younger heart failure population, the elderly heart failure 
population had more co-morbidities and more often HFpEF, in addition they received less life-
saving therapy. Mortality rates increased with age and were higher for HFrEF than HFpEF. 
Moreover, prognostic factors varied between different categories of heart failure. In spite of 
advanced treatment of ACS patients, post-ACS heart failure was still common and was coupled 
with worse quality of life.  
Conclusion: Heart failure in the elderly is a unique clinical entity, not only when it comes to 
clinical characteristics but also in prognosis and its influencing factors. In the elderly, co-
morbidities not only more often accompany heart failure but also affect the clinical phenotype 
and prognosis and therefore co-morbidities should be regarded as an important part of heart 
failure. 
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